Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.40
+0.19 (1.34%)
Apr 28, 2025, 9:42 AM EDT - Market open
Keros Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 559.93 | 331.15 | 279.05 | 230.04 | 265.88 | Upgrade
|
| Cash & Short-Term Investments | 559.93 | 331.15 | 279.05 | 230.04 | 265.88 | Upgrade
|
| Cash Growth | 69.09% | 18.67% | 21.30% | -13.48% | 3687.41% | Upgrade
|
| Accounts Receivable | 2.74 | 0.14 | - | 18 | - | Upgrade
|
| Other Receivables | 1.71 | 0.95 | 0.84 | 0.2 | 0.22 | Upgrade
|
| Receivables | 4.46 | 1.09 | 0.84 | 18.2 | 0.22 | Upgrade
|
| Prepaid Expenses | 1.73 | 1.64 | 2.28 | 1.38 | 0.97 | Upgrade
|
| Other Current Assets | 22.77 | 13.42 | 3.6 | 1.82 | 0.66 | Upgrade
|
| Total Current Assets | 588.89 | 347.29 | 285.77 | 251.44 | 267.73 | Upgrade
|
| Property, Plant & Equipment | 23.49 | 19.47 | 17.57 | 2.4 | 1.6 | Upgrade
|
| Other Long-Term Assets | 3.51 | 3.26 | 3.45 | 1.41 | 0.12 | Upgrade
|
| Total Assets | 615.89 | 370.03 | 306.78 | 255.25 | 269.44 | Upgrade
|
| Accounts Payable | 4.6 | 5.45 | 3.34 | 3.65 | 2.15 | Upgrade
|
| Accrued Expenses | 20.45 | 17.25 | 12 | 7.03 | 4.21 | Upgrade
|
| Current Portion of Leases | 1.98 | 1.01 | 0.46 | 0.86 | 0.42 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.11 | 0.19 | Upgrade
|
| Other Current Liabilities | 0.42 | 0.67 | 0.75 | 0.2 | 0.22 | Upgrade
|
| Total Current Liabilities | 27.45 | 24.37 | 16.55 | 11.85 | 7.18 | Upgrade
|
| Long-Term Leases | 16.88 | 13.44 | 12.81 | 0.23 | 0.48 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.06 | Upgrade
|
| Total Liabilities | 44.33 | 37.81 | 29.36 | 12.08 | 7.72 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,140 | 713.64 | 505.86 | 366.93 | 326.73 | Upgrade
|
| Retained Earnings | -568.78 | -381.43 | -228.43 | -123.76 | -65.01 | Upgrade
|
| Total Common Equity | 571.55 | 332.21 | 277.42 | 243.17 | 261.72 | Upgrade
|
| Shareholders' Equity | 571.55 | 332.21 | 277.42 | 243.17 | 261.72 | Upgrade
|
| Total Liabilities & Equity | 615.89 | 370.03 | 306.78 | 255.25 | 269.44 | Upgrade
|
| Total Debt | 18.86 | 14.44 | 13.27 | 1.09 | 0.9 | Upgrade
|
| Net Cash (Debt) | 541.07 | 316.7 | 265.78 | 228.95 | 264.98 | Upgrade
|
| Net Cash Growth | 70.84% | 19.16% | 16.09% | -13.60% | 33483.90% | Upgrade
|
| Net Cash Per Share | 14.45 | 10.75 | 10.53 | 9.81 | 17.09 | Upgrade
|
| Filing Date Shares Outstanding | 40.56 | 35.98 | 28.54 | 24 | 23.27 | Upgrade
|
| Total Common Shares Outstanding | 40.55 | 31.84 | 27.54 | 23.97 | 23.19 | Upgrade
|
| Working Capital | 561.44 | 322.92 | 269.22 | 239.59 | 260.54 | Upgrade
|
| Book Value Per Share | 14.09 | 10.43 | 10.07 | 10.14 | 11.28 | Upgrade
|
| Tangible Book Value | 571.55 | 332.21 | 277.42 | 243.17 | 261.72 | Upgrade
|
| Tangible Book Value Per Share | 14.09 | 10.43 | 10.07 | 10.14 | 11.28 | Upgrade
|
| Machinery | 7.19 | 5.85 | 2.97 | 1.92 | 1.19 | Upgrade
|
| Leasehold Improvements | - | - | 0.21 | 0.26 | 0.26 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.